Clinical trial INCA 0186-101
A Phase 1, Open-Label, Multicenter Study of INCA00186 as Monotherapy or in Combination With Immunotherapy in Participants With Advanced Solid Tumors
| Organ | Multiple |
|---|---|
| Trial status | Trial closed |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Incyte Corporate |
| EudraCT Identifier | 2021-001263-24 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04989387 |
| Last update |